Literature DB >> 30924083

Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.

Xin Huang1,2, Qiuyi Wang1,2, Tingting Liu1,2, Tianjiao Pei1,2, Dong Liu1,2, Huili Zhu1,2, Wei Huang3,4.   

Abstract

PURPOSE: Insulin resistance (IR) is a common feature of polycystic ovary syndrome (PCOS). Body fat indices can be predictive markers of IR. This study is aimed to predict IR in Chinese women with PCOS of different body types based on body fat indices.
METHODS: A total of 723 women diagnosed with PCOS according to Rotterdam criteria were recruited in this study and were further divided into two groups based on their BMI. All participants underwent physical examinations and ultrasound; and blood was collected from them on the days 3-5 of the menstrual cycle. Their BMI, waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), lipid accumulation product (LAP) index, visceral adiposity index (VAI), and the homeostasis model assessment index of insulin resistance (HOMA-IR) were calculated. The correlations between body fat indices and HOMA-IR and receiver operating characteristic (ROC) curves were evaluated.
RESULTS: In normal weight group (BMI < 24, n = 333), VAI (best cut-off value: 1.681, area under curve (AUC) = 0.754, P < 0.01) and LAP index (best cut-off value: 18.53, AUC = 0.734, P < 0.001) were the reliable indicators of IR based on HOMA-IR ≥ 2.77, while in overweight/obese group (BMI ≥ 24, n = 390), the BMI, WC, WHtR and LAP index had a significant correlation with HOMA-IR. The representative markers to assess IR were BMI (best cut-off value: 26.43, AUC = 0.644, P = 0.001) and WHtR (best cut-off value: 0.544, AUC = 0.604, P = 0.021).
CONCLUSIONS: Body fat indices are predictive markers of IR in Chinese PCOS women, especially in those with normal weight.

Entities:  

Keywords:  Body fat indexes; Body mass indexes; Insulin resistance; Polycystic ovary syndrome

Mesh:

Year:  2019        PMID: 30924083     DOI: 10.1007/s12020-019-01912-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  23 in total

1.  Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity.

Authors:  Julie-Anne Nazare; Jessica D Smith; Anne-Laure Borel; Steven M Haffner; Beverley Balkau; Robert Ross; Christine Massien; Natalie Alméras; Jean-Pierre Després
Journal:  Am J Clin Nutr       Date:  2012-08-29       Impact factor: 7.045

2.  [Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population].

Authors:  Beifan Zhou
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2002-02

Review 3.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

4.  Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.

Authors:  Giselle A Abruzzese; Gloria E Cerrrone; Juan M Gamez; Mabel N Graffigna; Susana Belli; Gustavo Lioy; Eduardo Mormandi; Patricia Otero; Oscar A Levalle; Alicia B Motta
Journal:  Horm Metab Res       Date:  2016-08-29       Impact factor: 2.936

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 6.  Ethnic differences: Is there an Asian phenotype for polycystic ovarian syndrome?

Authors:  Zhongwei Huang; Eu-Leong Yong
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-05-18       Impact factor: 5.237

7.  Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations.

Authors:  Ming Li; Robyn A McDermott
Journal:  Diabetes Res Clin Pract       Date:  2010-01-19       Impact factor: 5.602

Review 8.  Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

Authors:  H Teede; A Deeks; L Moran
Journal:  BMC Med       Date:  2010-06-30       Impact factor: 8.775

9.  The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison.

Authors:  Henry S Kahn
Journal:  BMC Cardiovasc Disord       Date:  2005-09-08       Impact factor: 2.298

10.  Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly.

Authors:  Anna Karla Carneiro Roriz; Luiz Carlos Santana Passos; Carolina Cunha de Oliveira; Michaela Eickemberg; Pricilla de Almeida Moreira; Lílian Ramos Sampaio
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

View more
  9 in total

1.  Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.

Authors:  Hurjahan Banu; Md Shahed Morshed; Tania Sultana; Sukanti Shah; Shazia Afrine; M A Hasanat
Journal:  J Hum Reprod Sci       Date:  2022-03-31

2.  Increased serum fetuin-B concentration is associated with HOMA-β and indices of liver steatosis in women with polycystic ovary syndrome: a pilot study.

Authors:  Agnieszka Adamska; Aleksandra Maria Polak; Anna Krentowska; Agnieszka Łebkowska; Justyna Hryniewicka; Monika Leśniewska; Irina Kowalska
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

3.  Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population.

Authors:  Juncheol Lee; Bongyoung Kim; Wonhee Kim; Chiwon Ahn; Hyun Young Choi; Jae Guk Kim; Jihoon Kim; Hyungoo Shin; Jun Goo Kang; Shinje Moon
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

4.  Anti-Müllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS.

Authors:  Xiying Zeng; Yinxiang Huang; Mulin Zhang; Yun Chen; Jiawen Ye; Yan Han; Danyan Ma; Xin Zheng; Xiaohong Yan; Changqin Liu
Journal:  Endocr Connect       Date:  2022-01-10       Impact factor: 3.335

Review 5.  Markers of insulin resistance in Polycystic ovary syndrome women: An update.

Authors:  Chantal Anifa Amisi
Journal:  World J Diabetes       Date:  2022-03-15

6.  Construction of a Personalized Insulin Resistance Risk Assessment Tool in Xinjiang Kazakhs Based on Lipid- and Obesity-Related Indices.

Authors:  Linzhi Yu; Yu Li; Rulin Ma; Heng Guo; Xianghui Zhang; Yizhong Yan; Jia He; Xinping Wang; Qiang Niu; Shuxia Guo
Journal:  Risk Manag Healthc Policy       Date:  2022-04-13

7.  Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela.

Authors:  Valmore Bermúdez; Juan Salazar; Jorge Fuenmayor; Manuel Nava; Ángel Ortega; Pablo Duran; Milagros Rojas; Roberto Añez; Alejandra Rivas-Montenegro; Lissé Angarita; Maricarmen Chacín; Clímaco Cano; Manuel Velasco; Joselyn Rojas
Journal:  J Obes       Date:  2021-06-07

8.  Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China.

Authors:  Chen Huanan; Li Sangsang; Adwoa Nyantakyiwaa Amoah; Bo Yacong; Chen Xuejiao; Shi Zhan; Wan Guodong; Huang Jian; Shi Songhe; Lyu Quanjun
Journal:  BMJ Open       Date:  2020-11-27       Impact factor: 2.692

9.  Elevated Anti-Müllerian Hormone Is an Independent Risk Factor for Preterm Birth Among Patients With Overweight Polycystic Ovary Syndrome.

Authors:  Mingze Du; Junwei Zhang; Xiaona Yu; Yichun Guan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-08       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.